|
Insider Trading: Orexigen Therapeutics, Inc.
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Orexigen Therapeutics, Inc. in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Orexigen Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Orexigen Therapeutics, Inc. since 2005.
The reporting company's ticker symbol is OREX.
The reporting company's CIK number is 1382911.
The total value of stock buying since 2005 is $40,010,784.
The total value of stock sales is $8,572,771.
The total value of stock exercises is $189,113.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Orexigen Therapeutics, Inc. (OREX) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 -
Figure 2. Average prices of insider buys, sales, and option exercises at Orexigen Therapeutics, Inc. (OREX) in the past 24 months. See table 2 for insider transaction details.
09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Orexigen Therapeutics, Inc. (OREX).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-08 | 0 | 0 | 74,659 | 867,180 | 64,559 | 112,681 |
| 2007-12 | 0 | 0 | 36,166 | 523,914 | 36,166 | 38,216 |
| 2007-11 | 0 | 0 | 475,120 | 7,181,677 | 36,166 | 38,216 |
| 2007-05 | 3,174,232 | 38,090,784 | 0 | 0 | 0 | 0 |
| 2007-04 | 160,000 | 1,920,000 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Orexigen Therapeutics, Inc. (OREX)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-08-25 | Mckinney Anthony A (Chief Business Officer) | Sale | 3,000 | 12.02 | 36,060 |
| 2008-08-25 | Mckinney Anthony A (Chief Business Officer) | Option Exercise | 3,000 | .10 | 300 |
| 2008-08-25 | Landbloom Ronald P (VP, Medical and Regulatory) | Sale | 40,000 | 11.28 | 451,200 |
| 2008-08-25 | Landbloom Ronald P (VP, Medical and Regulatory) | Option Exercise | 40,000 | 2.00 | 80,000 |
| 2008-08-25 | Bymaster Franklin P (VP, Neuroscience) | Sale | 1,800 | 12.00 | 21,600 |
| 2008-08-25 | Bymaster Franklin P (VP, Neuroscience) | Option Exercise | 1,800 | 2.00 | 3,600 |
| 2008-08-25 | Powell Michael (Director) | Sale | 4,800 | 12.00 | 57,612 |
| 2008-08-21 | Cooper Graham K (CFO and Treasurer) | Sale | 8,259 | 12.00 | 99,108 |
| 2008-08-21 | Cooper Graham K (CFO and Treasurer) | Option Exercise | 8,259 | .70 | 5,781 |
| 2008-08-21 | Dunayevich Eduardo (Chief Medical Officer) | Sale | 8,259 | 12.00 | 99,108 |
| 2008-08-21 | Dunayevich Eduardo (Chief Medical Officer) | Option Exercise | 8,259 | 2.00 | 16,518 |
| 2008-08-21 | Bymaster Franklin P (VP, Neuroscience) | Sale | 3,241 | 12.00 | 38,892 |
| 2008-08-21 | Bymaster Franklin P (VP, Neuroscience) | Option Exercise | 3,241 | 2.00 | 6,482 |
| 2008-08-21 | Powell Michael (Director) | Sale | 5,300 | 12.00 | 63,600 |
| 2007-12-26 | Mckinney Anthony A (Chief Operating Officer) | Sale | 4,166 | 15.02 | 62,589 |
| 2007-12-26 | Mckinney Anthony A (Chief Operating Officer) | Option Exercise | 4,166 | .10 | 416 |
| 2007-12-26 | Lancaster James C Jr (VP of Commercial Operations) | Sale | 3,000 | 15.02 | 45,072 |
| 2007-12-26 | Lancaster James C Jr (VP of Commercial Operations) | Option Exercise | 3,000 | 2.00 | 6,000 |
| 2007-12-26 | Landbloom Ronald P (VP, Medical and Regulatory) | Sale | 5,000 | 15.02 | 75,120 |
| 2007-12-26 | Landbloom Ronald P (VP, Medical and Regulatory) | Option Exercise | 5,000 | 2.00 | 10,000 |
| 2007-12-20 | Cooper Graham K (CFO and Treasurer) | Sale | 4,000 | 14.10 | 56,400 |
| 2007-12-20 | Cooper Graham K (CFO and Treasurer) | Option Exercise | 4,000 | .70 | 2,800 |
| 2007-12-20 | Dunayevich Eduardo (Chief Medical Officer) | Sale | 5,000 | 14.10 | 70,500 |
| 2007-12-20 | Dunayevich Eduardo (Chief Medical Officer) | Option Exercise | 5,000 | 2.00 | 10,000 |
| 2007-12-17 | Tollefson Gary D (President and CEO) | Sale | 15,000 | 14.28 | 214,233 |
| 2007-12-17 | Tollefson Gary D (President and CEO) | Option Exercise | 15,000 | .60 | 9,000 |
| 2007-11-29 | Cowley Michael A (Chief Scientific Officer) | Sale | 35,156 | 14.28 | 501,851 |
| 2007-11-27 | More Robert J (10% Owner) | Sale | 21,000 | 14.27 | 299,670 |
| 2007-11-27 | Schoemaker Kathleen K (10% Owner) | Sale | 21,000 | 14.27 | 299,670 |
| 2007-11-27 | Dovey Brian H (Director) | Sale | 21,000 | 14.27 | 299,670 |
| 2007-11-27 | Dp V Associates Lp (10% Owner) | Sale | 21,000 | 14.27 | 299,670 |
| 2007-11-27 | Blair James C (10% Owner) | Sale | 21,000 | 14.27 | 299,670 |
| 2007-11-27 | Treu Jesse I (10% Owner) | Sale | 21,000 | 14.27 | 299,670 |
| 2007-11-26 | Mckinney Anthony A (Chief Operating Officer) | Sale | 4,166 | 14.41 | 60,048 |
| 2007-11-26 | Mckinney Anthony A (Chief Operating Officer) | Option Exercise | 4,166 | .10 | 416 |
| 2007-11-26 | Lancaster James C Jr (VP of Commercial Operations) | Sale | 3,000 | 14.41 | 43,241 |
| 2007-11-26 | Lancaster James C Jr (VP of Commercial Operations) | Option Exercise | 3,000 | 2.00 | 6,000 |
| 2007-11-26 | Landbloom Ronald P (VP, Medical and Regulatory) | Sale | 5,000 | 14.41 | 72,069 |
| 2007-11-26 | Landbloom Ronald P (VP, Medical and Regulatory) | Option Exercise | 5,000 | 2.00 | 10,000 |
| 2007-11-21 | Scale Venture Management Ii, Llc (10% Owner) | Sale | 100 | 15.00 | 1,500 |
| 2007-11-21 | Bock Louis C (Director) | Sale | 100 | 15.00 | 1,500 |
| 2007-11-20 | Cooper Graham K (CFO and Treasurer) | Sale | 4,000 | 14.75 | 58,985 |
| 2007-11-20 | Cooper Graham K (CFO and Treasurer) | Option Exercise | 4,000 | .70 | 2,800 |
| 2007-11-20 | Dunayevich Eduardo (Chief Medical Officer) | Sale | 5,000 | 14.75 | 73,731 |
| 2007-11-20 | Dunayevich Eduardo (Chief Medical Officer) | Option Exercise | 5,000 | 2.00 | 10,000 |
| 2007-11-20 | Scale Venture Management Ii, Llc (10% Owner) | Sale | 600 | 15.00 | 9,000 |
| 2007-11-20 | Bock Louis C (Director) | Sale | 600 | 15.00 | 9,000 |
| 2007-11-19 | Scale Venture Management Ii, Llc (10% Owner) | Sale | 2,200 | 15.07 | 33,147 |
| 2007-11-19 | Bock Louis C (Director) | Sale | 2,200 | 15.07 | 33,147 |
| 2007-11-16 | Scale Venture Management Ii, Llc (10% Owner) | Sale | 46,561 | 15.61 | 728,134 |
| 2007-11-16 | Bock Louis C (Director) | Sale | 46,561 | 15.61 | 728,134 |
| 2007-11-15 | Scale Venture Management Ii, Llc (10% Owner) | Sale | 30,000 | 15.55 | 467,313 |
| 2007-11-15 | Tollefson Gary D (President and CEO) | Sale | 15,000 | 15.68 | 235,240 |
| 2007-11-15 | Tollefson Gary D (President and CEO) | Option Exercise | 15,000 | .60 | 9,000 |
| 2007-11-15 | Bock Louis C (Director) | Sale | 30,000 | 15.55 | 467,313 |
| 2007-11-14 | Scale Venture Management Ii, Llc (10% Owner) | Sale | 518 | 15.99 | 8,282 |
| 2007-11-14 | Bock Louis C (Director) | Sale | 518 | 15.99 | 8,282 |
| 2007-05-01 | More Robert J (10% Owner) | Purchase | 525,000 | 12.00 | 6,300,000 |
| 2007-05-01 | Schoemaker Kathleen K (10% Owner) | Purchase | 525,000 | 12.00 | 6,300,000 |
| 2007-05-01 | Dovey Brian H (Director) | Purchase | 525,000 | 12.00 | 6,300,000 |
| 2007-05-01 | Domain Partners V Lp (10% Owner) | Purchase | 512,884 | 12.00 | 6,154,608 |
| 2007-05-01 | Dp V Associates Lp (10% Owner) | Purchase | 24,232 | 12.00 | 290,784 |
| 2007-05-01 | Blair James C (10% Owner) | Purchase | 525,000 | 12.00 | 6,300,000 |
| 2007-05-01 | Treu Jesse I (10% Owner) | Purchase | 525,000 | 12.00 | 6,300,000 |
| 2007-04-26 | Weber Eckard (Director) | Purchase | 160,000 | 12.00 | 1,920,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Orexigen Therapeutics, Inc. (symbol OREX,
CIK number 1382911) see
the Securities and Exchange Commission (SEC) website.
|
|
